Watch the webinar: Understanding and managing suicidal risk
Suicidal risk and understanding how best to respond was the [...]
UKABIF leads charge for better ABI support in Wales
A report which sets out recommendations to improve services and [...]
Groundbreaking clinic uses AI in dementia fight
A revolutionary AI-led approach to detecting pre-dementia symptoms is to form part of a new NHS clinic dedicated to driving improvements in early-stage dementia diagnosis.
Cognetivity’s technology is to be deployed within a new remote Brain Health Clinic at South London and Maudsley (SLaM) NHS Foundation Trust. Among the first of its kind in the world, the clinic will provide in-depth subtyping of patients with mild cognitive impairment (MCI), followed by periodic, remote assessment of those who are expected to progress to Alzheimer's dementia. The Integrated Cognitive Assessment (ICA) devised by Cognetivity will play a key role in the clinic’s aim of enhancing early diagnosis of patients with Alzheimer’s disease and provide timely access to treatment. Cognetivity’s iPad-based test also supports the clinic's focus on remote medical assessment, the importance of which has been reinforced by the ongoing COVID-19 pandemic.
NeuroBall™: enabling progress in rehabilitation
What impact can the NeuroBall™ have on rehabilitation? Claire Everett, neurophysiotherapist at PhysioFunction, shares her insights into its benefits
What are the main benefits of NeuroBall™:- For your clients/patients?
- For your clinic?
Largest-ever brain cancer clinical trial underway
Working with seven UK hospitals, including the National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH, 119 patients with glioblastoma have been recruited in just over two years to the IPI-GLIO trial.
Glioblastoma is a very aggressive brain tumour with around 2,200 cases diagnosed each year in England (and around 3,200 across the UK). The average survival time is around 15 months, with fewer than 10 per cent of patients alive five years after diagnosis following standard treatment. In the Phase II Clinical trial, following standard treatment for glioblastoma of surgery, where appropriate, radiotherapy and chemotherapy, patients were given ipilimumab, a drug that has seen significant improvements in survival rates for people with melanoma skin cancer. The drug blocks a key regulator in the immune system, making the immune system more active. Study participants will be followed up over the next 18 months and the findings will be presented to the American Society of Clinical Oncology in May 2023.
‘It’s a privilege to be able to help others’
Amy Crosby has created Evolve Case Management to deliver specialist support to people with brain and spinal injuries, building on her career in nursing and case management, as well as her personal experience of life-changing injury.
After her father sustained a TBI in 2015 after falling down some stairs, resulting in a frontal lobe craniotomy and a five-month stay in hospital, Amy saw first-hand how vital and badly-needed support is post-discharge, for individuals and their families alike. “I realised then how little I knew about brain injury. As a nurse, you’re used to being able to fix things, but brain injury is very different. My dad couldn’t fit into the world he used to live in, which he thought he could go back to, and there was no support or education for us as a family,” she recalls.
Brain mapping targets neuropsychiatric symptoms
Researchers have made significant advancements in correlating aberrations in specific brain circuits with neuropsychiatric conditions like depression.
However, it remains difficult to prove that damage to these circuits causes the symptoms themselves and that targeting them with therapeutics could help patients. By integrating brain lesion datasets with data on how two treatments - deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) - influence neuropsychiatric disorders, researchers from Brigham and Women's Hospital and collaborators developed a new brain mapping approach that may help clarify the cause of a variety of neuropsychiatric conditions and identify promising stimulation sites to target therapeutically.
Online arts therapy sessions to continue
Good news for groundbreaking programme that fuses art with recovery.
TBI in UK Armed Forces to be investigated
A new study is to investigate traumatic brain injury in [...]
